Overview:

Desmoid tumors are rare, locally aggressive mesenchymal tumors driven by molecular alterations in the Wnt/APC/β-catenin pathway. Diagnosis remains difficult in community practice, with misdiagnosis occurring in 30%-40% of cases and prolonged diagnostic delays. Many clinicians remain uncertain about molecular workflows, genetic counseling, and how to sequence and manage toxicity from novel therapies.

This program will be delivered as a series of 8 live, CME-certified virtual meetings in collaboration with ACCC-affiliated Oncology State Societies, supported by an enduring online activity. Using an interactive, case-based format tailored to community oncology practice, these virtual meetings include expert presentations on recent data from clinical trials of desmoid tumors, followed by case presentations, discussions and learner question and answers. The initiative is designed to translate evolving clinical evidence into practical, real-world decision-making and support personalized care for patients with desmoid tumors.

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Apply guideline-based recommendations to overcome diagnostic challenges and ensure accurate identification of desmoid tumors
• Integrate emerging evidence on novel therapies into personalized treatment strategies for patients with desmoid tumors
• Develop multidisciplinary strategies to manage adverse events (AEs) in patients receiving novel therapies for the treatment of desmoid tumors

Target Audience:

This educational program is primarily directed toward community-based oncologists,  advanced practice providers, nurses, and other health care professionals involved in the  treatment of desmoid tumors.

Accreditation/Credit Designation:

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour. 

Acknowledgment of Educational Support

This activity is supported by an educational grant from SpringWorks Therapeutics, Inc.

Have a question for the PER® team?

Oncology Inquiries: onc-info@gotoper.com

Eye Care Inquiries: eye-info@gotoper.com

Multispecialty Inquiries: multi-info@gotoper.com